Urothelial carcinoma, or transitional cell carcinoma, is the most common bladder cancer and grows in the urothelial cells lining the urinary tract. Skip to main content . Home ; ...

This trial looked at celecoxib for a very early type of bladder cancer called superficial transitional cell bladder cancer. It was supported by Cancer Research UK. When this trial was done, doctors ...

This cancer is also referred to as transitional cell cancer. More on the FDA Approval of This Combination. Prior to the presentation at the meeting, on December 15, 2023, the FDA approved Padcev ...

Multiple therapeutic options are available for the management of patients with upper urinary tract transitional cell carcinoma (TCC). Radical nephroureterectomy with an ipsilateral bladder cuff is ...

In a pre-conference interview with dvm360, Craig A Clifford, DVM, MS, DACVIM (Oncology), talked about the most common bladder tumor in canines: transitional cell carcinoma, or urothelial carcinoma.In ...

Transitional cell carcinoma, a type of cancer most commonly seen in a dog's bladder, may respond to ivermectin in the same way as human renal cell carcinoma. Unfortunately, there is not yet any ...

Transitional cell carcinoma (TCC) kidney cancer is a type of cancer in the lining of the kidney or the ureters. The ureters are the tubes that carry urine from the kidneys to the bladder.

Most prostate cancer is slow-growing and treatable. But one type that’s rare is often deadly. Learn about transitional cell or urothelial carcinoma.

It used to be called transitional cell cancer (TCC) of the kidney or ureter. This is because it starts in cells called transitional cells. There are many different types of cells in the body, each ...

The standard treatment for muscle-invasive and metastatic bladder cancer is cisplatin-based chemotherapy. 1 Because outcomes are grim for patients who are poor candidates for platinum chemotherapy or ...

Anthrax is best known as a bioweapon. But researchers have figured out how to tweak the deadly toxin and use it to fight cancer. So far, dogs are the first to benefit from the new therapy.